Doctor100 Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $805K

  • Investors
  • 3

Doctor100 General Information

Description

Developer of high-functional health foods and drug materials intended for targeting the super-aging society. The company develops bio-natural medicines based on the development of raw materials and active ingredients derived from natural products and develops a product that processes natural herbal medicine ingredients through herbal methods through its own fermentation and conversion technology, enabling users and patients to prevent and improve the vascular system and metabolic diseases that are prevalent among adults around the world, such as diabetes and high blood pressure.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 556 Sicheong-ro
  • Paltan-myeon
  • Hwaseong, Gyeonggi
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 556 Sicheong-ro
  • Paltan-myeon
  • Hwaseong, Gyeonggi
  • South Korea
+82

Doctor100 Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Doctor100 Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 07-Jun-2024 $805K Completed Generating Revenue
2. Accelerator/Incubator 25-Dec-2023 Completed Generating Revenue
1. Seed Round 24-May-2023 Completed Generating Revenue
To view Doctor100’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Doctor100 Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Doctor100 Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Korea Alternative Investment Corporation Asset Manager
Tech Incubator Program for Startup Accelerator/Incubator
New Paradigm Investment Accelerator/Incubator Minority
To view Doctor100’s complete investors history, request access »

Doctor100 FAQs

  • When was Doctor100 founded?

    Doctor100 was founded in 2017.

  • Where is Doctor100 headquartered?

    Doctor100 is headquartered in Hwaseong, South Korea.

  • What is the size of Doctor100?

    Doctor100 has 7 total employees.

  • What industry is Doctor100 in?

    Doctor100’s primary industry is Drug Discovery.

  • Is Doctor100 a private or public company?

    Doctor100 is a Private company.

  • What is Doctor100’s current revenue?

    The current revenue for Doctor100 is .

  • How much funding has Doctor100 raised over time?

    Doctor100 has raised $1.19M.

  • Who are Doctor100’s investors?

    Korea Alternative Investment Corporation, Tech Incubator Program for Startup, and New Paradigm Investment have invested in Doctor100.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process